Chemotherapy : proceedings of the International Congress of Pharmacology, Paris, 1978 / editor, M. Adolphe.
Advances in Pharmacology and Therapeutics, Volume 10: Chemotherapy covers the proceedings of the 7th International Congress of Pharmacology. The title presents papers that detail the advancement of pharmacological research in chemotherapy. The text first covers the chemotherapy of schistosomiasis. N...
Saved in:
Online Access: |
Full Text (via ScienceDirect) |
---|---|
Corporate Author: | |
Other Authors: | |
Format: | Conference Proceeding eBook |
Language: | English |
Published: |
Oxford [England] ; Elmsford, New York :
Pergamon Press,
1979.
|
Series: | Advances in Pharmacology and Therapeutics ;
Volume 10. |
Subjects: |
Table of Contents:
- Front Cover; Chemotherapy; Copyright Page; Table of Contents; Introduction; Part 1: Chemotherapy of Schistosomiasis; Chapter 1. Recent Advances in the Experimental Chemotherapy of Schistosomiasis; Chapter 2. Antischistosomal Activity of a Nitrodiphenyl-aminoisothiocyanate (C 9333-Go/CGP 4540) against Schistosoma Japonicum (Philippine Strain) in Mice and Rabbits; SUMMARY; INTRODUCTION; MATERIALS AND METHODS; RESULT; DISCUSSION; ACKNOWLEDGEMENT; REFERENCES.
- Chapter 3. 4-Isothioeyanato-4' -Nitrodiphenylamine (C 9333-Go/CGP 4540), an Antischistosomal Compound with an Unusual Spectrum of Anthelminthic Activity Against Intestinal Nematodes, Filariae and TrematodesABSTRACT; 1. INTRODUCTION; 2. MATERIALS AND METHODS; 3. RESULTS; 4. DISCUSSION AND CONCLUSIONS; 5. REFERENCES; Chapter 4. Clinical Experience with Oxamniquine; PATIENTS TREATED IN THE HOSPITAL ENVIRONMENT; PATIENTS TREATED IN ENDEMIC AREAS; DISCUSSION; REFERENCES; Chapter 5. Clinical Experiences with, and Pharmacokinetics of, Oxamniquine.
- Chapter 6. Progress in the Chemotherapy of SchistosomiasisMETRIFONATE (BILARCIL (R)); OXAMNIQUINE (MANSIL (R)); IA-4 N-OXIDE 5); AMOSCANATE (C9333-Go/CGP 4540); R0 11-0761 ; 35 972 R.P; 80.647 (SP 647); PRAZIQUANTEL (BILTRICIDE (R)); REFERENCES; Chapter 7. New Approaches Towards the Development of Safer Schistosomicidal Drugs; ABSTRACT; REFERENCES; Part 2: New Trends in Malaria Chemotherapy; Chapter 8. Some Promising Leads in Experimental Antimalarial Drugs; Quinoline methanols; WR142490: Mefloquine; 9-Phenanthrenemethanols; Quinazolines.
- Chapter 9. Experimental Infections with Human Plasmodia in Owl Monkeys
- Their Contri-butionsto Development of New Broadly Active Blood Schizonticidal DrugsABSTRACT; INTRODUCTION; EXPERIMENTAL; COMMENT; REFERENCES; Chapter 10. Drug Combination in Malaria; 1. Introduction; 2. Rationale for Combining Drugs in Anti-infectious Chemotherapy; 3. Choice of a Combination Partner; 4. Conclusion; References; Chapter 11. The U.S. Army Drug Development Program; INTRODUCTION; METHODS; RESULTS; SUMMARY AND CONCLUSIONS; REFERENCES.
- Chapter 12. The Role of the World Health Organization in the Development of New AntimalarialsABSTRACT; INTRODUCTION; THE MALARIA SITUATION; PRESENT MEANS AND CONSTRAINTS OF MALARIA CONTROL; PRESENT CONCEPT OF MALARIA CONTROL; PRESENT ROLE OF DRUGS IN ANTIMALARIA OPERATIONS; MALARIA RESEARCH IN THE PROGRAMME OF WHO; REFERENCES; Part 3: New Trends in Cancer Chemotherapy and their Pharmacological Basis; Chapter 13. Cancer Chemotherapy
- An Overview; References; Chapter 14. Recent Studies on Antitumor Antibiotics; BLEOMYCIN; ANTHRACYCLINE ANTIBIOTICS; NEOTHRAMYCIN.